ArticleScientific reports2026

miR-340 improves the efficiency of p53 gene therapy in metastatic prostate cancer cells through downregulation of MDM2.

Roham Deyhimfar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.